Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis

Project description

Studying the Epstein-Barr virus link to MS

Multiple Sclerosis (MS) is a chronic disease that affects the brain and spinal cord, often leading to disability over time. While treatments can slow the progression, they cannot stop it completely. A major breakthrough came with the discovery that Epstein-Barr virus (EBV) infection is a significant risk factor for MS. This finding has opened new paths for research into the causes of the disease. With this in mind, the EU-funded BEHIND-MS project aims to understand how EBV triggers MS by studying the virus’ interaction with the immune system in patients. By developing new models and testing treatments, the project hopes to improve diagnosis and therapy options, ultimately reducing the burden of MS on patients and society.

Objective

Multiple Sclerosis (MS) is the most frequent neuroinflammatory disease. Despite new treatments that slow the progression of the disease, patients with MS (PwMS) frequently evolve towards major disability. The pathogenesis of MS is controversially debated, but the recent discovery that infection with the Epstein-Barr virus (EBV) is a major risk factor will radically change research avenues. The BEHIND-MS consortium ambitions to understand how EBV promotes MS development. To this end, we have established a multidisciplinary team that will for the first time draw a comprehensive map of the interactions between the virus and all arms of the immune system in the blood and brain of PwMS and how they ultimately lead to neural damage, in the context of genetic risk factors. We will also develop an in vitro model of MS that integrates the virus, the immune system and brain cells reprogrammed from the blood of the same PwMS. Thus, for the first time, we will study in the laboratory the complex molecular mechanisms that give rise to MS. Finally, we will develop an animal model of prodromal MS that would be a ‘game changer’ for our understanding of MS pathogenesis and allow testing of promising new treatments. The pivotal knowledge developed in this project will empower the entire healthcare value chain to work towards better clinical management of MS. A detailed understanding of EBV-MS interactions, combined with newly identified biomarkers, and study models will open the doors for researchers, clinicians and industry to capitalize on the mechanisms underlying EBV-MS interactions, and develop new diagnostic, preventive and therapeutic tools and guidelines. Throughout the project, an open dialogue with the main stakeholder representatives will ensure a mutual understanding of patient needs and project results. Ultimately, by contributing to improved risk analysis, stratification and treatment strategies, BEHIND-MS has the potential to reduce the burden of MS on society.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-HLTH-2023-DISEASE-03

See all projects funded under this call

Coordinator

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Net EU contribution
€ 3 716 056,25
Address
IM NEUENHEIMER FELD 280
69120 Heidelberg
Germany
Region
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Activity type
Research Organisations
Links
Total cost
€ 3 716 056,25

Participants (11)

Partners (1)